Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for Mild Cognitive Impairment in Parkinson's Disease
NCT05709301Phase 2Unknown
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Oct 2023
- Primary completion
- Nov 2025
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of donepezil in Mild Cognitive Impairment (MCI), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Status: unknown.
02
Drugs
donepezil
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT05709301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05709301.